Oct 7 (edited) in Daily Stock Post
bluebird bio (NASDAQ: BLUE)
This is not investment advice; it’s a trade idea for educational purposes. All trades are inherently risky and may result in a loss. Please do your own research.
--------------------------------
bluebird bio is a biotechnology company that focuses on developing gene therapies for severe genetic diseases and cancer. Their core mission is to deliver transformative gene therapies to patients with few or no treatment options. Their lead product candidates target conditions such as cerebral adrenoleukodystrophy (CALD), sickle cell disease, and beta-thalassemia. BLUE has been a subject of significant attention due to its cutting-edge gene-editing technologies and clinical trial advancements.
From a technical analysis standpoint, BLUE is encountering significant support and resistance levels that can guide near-term price action.
Support Levels
- The recent all-time low around $0.45, reached in early October 2024, acts as a critical support level. This price point reflects a historical low, and should the stock test this level again, it will be important to monitor whether buyers step in to prevent further declines.
- The next support level appears near $0.50, which is slightly above the all-time low, representing a psychological level where buyers might find value.
Resistance Levels:
- A significant resistance level is around $0.70, where the stock has faced selling pressure. This level is important because breaking above it could indicate a shift toward a bullish trend, with more upward momentum.
- Further resistance is expected near $1.00, which would be a key psychological barrier. Overcoming this could signal the potential for more gains if accompanied by positive news or developments.
In the short term, BLUE's technical chart shows the stock is trading in a neutral range with significant overhead resistance, and buyers may defend the support at around $0.45.
I bought this stock this morning at around $.54 with a short-term hold plan. It is trading above its 50-day and 200-day simple moving averages, typically seen as a bullish indicator. However, the 50-day moving average is below the 200-day average, giving a strong bearish signal. This suggests potential downward pressure in the near term if this trend continues, hence the short-term hold plan.
0
1 comment
bluebird bio (NASDAQ: BLUE)
skool.com/daily-stock-tip-6173
THIS IS NOT INVESTMENT ADVICE. This group will have a daily stock tip posted. This is for purely entertainment and educational purposes only
powered by